ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ketamine"
Episode Synopsis
Rafael Coira, MD, JD and James Sherer, MD discuss the new FDA approval of the Esketamine nasal spray for treatment of depression. Marketed under the trade name Spravato, Esketamine promises to reverse depression in one day, but what are the risks of taking a medication derived from the drug PCP?
More episodes of the podcast The Psychiatrists Guide
Social Media Addiction
21/05/2024
ADHD in a Nutshell
10/07/2023
RO-DBT (Part I)
08/02/2023
Children of War in Ukraine
18/09/2022
Diagnosing ADHD in Adults
28/08/2022
Internet Gaming Disorder and ADHD
28/03/2022
How to Make Friends (According to DBT)
13/10/2021
My Lie By Omission
18/07/2021
Anorexia Nervosa
20/06/2021
FDA Approved Video Game Treats ADHD
31/01/2021
In God we trust